论文信息 - Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial. - 字舞流文

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.

Kazuhiro Yoshida | Masato Nakamura | H. Matsumoto | K. Muro | S. Morita | H. Baba | Masahiko Watanabe | K. Sugihara | T. Satoh | Y. Shimada | Y. Sakata | Y. Sasaki | Yasuhide Yamada | D. Takahari | Y. Komatsu | Keiichi Takahashi | H. Mishima | S. Iwamoto | Motoki Yoshida | K. Shimada | M. Watanabe | Y. Yamada | M. Yoshida